The “STRING” enrichment analysis of inflammatory biomarkers which are activated in male FD patients with HCM confirms the involvement of cytokine–cytokine interaction, the cytokine-mediated signaling pathway, the T-cell signaling pathway, and the NF-kB/Il-17 signaling pathway in patients with FD with the presence of HCM. This evidence concerns the gene IL17A and Fabry disease.